OTC:GOVX
GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight
GeoVax Labs shares closed Monday at $2.21, up 79.7%, after the small vaccine developer announced a $3 million private placement and leaned into investor interest around biodefense preparedness. The stock was indicated lower in…
Company hubOTC:GOVX
GeoVax (GOVX) Stock News & Analysis
Follow the latest GeoVax (GOVX) company news, earnings coverage and investor analysis from TechStock².
Save this hub to your TS2 Signalbook account.
- Latest update
- Articles in this hub
- 1
- Last 30 days
- 0
What investors are watching
- Earnings, guidance and financial performance
- Valuation, trading activity and market sentiment
- Strategy, catalysts and company-specific risks
All coverage